03/25/2024 3:05 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 6:15 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 11:45 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/09/2024 7:35 AM | BioXcel Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024 4:27 PM | BioXcel Therapeutics (Filer)
| Form 424B5 | |
02/08/2024 6:08 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
02/07/2024 6:27 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) BioXcel Therapeutics (Subject)
| Form SC 13G/A | |
01/22/2024 11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
12/18/2023 3:52 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:54 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:55 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:57 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 3:47 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 6:22 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2023 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 11:15 PM | BioXcel Therapeutics (Filer)
| Form EFFECT | |
11/13/2023 10:59 AM | BioXcel Therapeutics (Filer)
| Form RW WD | |
11/13/2023 9:23 AM | BioXcel Therapeutics (Filer)
| Form RW | |
11/02/2023 5:01 AM | BioXcel Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/19/2023 3:48 PM | BioXcel Holdings, Inc. (Filed by) BioXcel Therapeutics (Subject)
| Form SC 13G/A | |
10/13/2023 3:01 PM | BioXcel Therapeutics (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
10/10/2023 8:09 AM | BioXcel Therapeutics (Subject) FIL Ltd (Filed by)
| Form SC 13G/A | |
10/10/2023 6:06 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/04/2023 6:05 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 4:07 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2023 10:21 AM | BioXcel Therapeutics (Subject) Mueller Family 2010 Irrevocable Trust (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 9:55 AM | BioXcel Therapeutics (Subject) MUELLER PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2023 10:15 AM | BioXcel Therapeutics (Subject) Peter Mueller 2018 Irrevocable Family Trust (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023 7:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 3:47 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:47 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:48 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:49 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2023 3:49 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/12/2023 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/22/2023 6:01 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 8:11 AM | BioXcel Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023 6:20 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
A lot of people are making this costly mistake (Ad) You may have heard the saying “options are risky” …
And, they can be. But only if you use them the way a lot of folks do.
A lot of people think of BUYING speculative options when they talk about options.
And BUYING low probability, speculative options is definitely risky…
It’s how some folks leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. Click here to jump in on the next one |
06/30/2023 3:17 PM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2023 5:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2023 3:58 PM | BioXcel Therapeutics (Issuer) Laumas Sandeep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 3:59 PM | BioXcel Therapeutics (Issuer) MILLER MICHAEL PATRICK (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 4:01 PM | BioXcel Therapeutics (Issuer) MUELLER PETER (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/28/2023 4:02 PM | BioXcel Therapeutics (Issuer) Bray June (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2023 11:28 AM | BioXcel Therapeutics (Subject) Mueller Family 2010 Irrevocable Trust (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023 11:20 AM | BioXcel Therapeutics (Subject) Peter Mueller 2018 Irrevocable Family Trust (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023 11:05 AM | BioXcel Therapeutics (Subject) MUELLER PETER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023 5:42 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:44 PM | BioXcel Therapeutics (Issuer) Yocca Frank (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:46 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:36 PM | BioXcel Therapeutics (Issuer) O'Neill Vincent (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2023 5:40 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/15/2023 1:13 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023 3:37 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2023 2:26 PM | BioXcel Therapeutics (Subject) Mehta Vimal (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2023 7:29 PM | BioXcel Therapeutics (Issuer) Rodriguez Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 7:32 PM | BioXcel Therapeutics (Issuer) Steinhart Richard I (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 7:33 PM | BioXcel Therapeutics (Issuer) Mehta Vimal (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2023 8:54 AM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144/A | |
05/15/2023 11:04 AM | BioXcel Therapeutics (Subject) Steinhart Richard I (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2023 9:52 AM | BioXcel Therapeutics (Subject) Rodriguez Javier (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2023 7:30 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2023 2:19 PM | Aiello Michael James (Reporting) BioXcel Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/20/2023 6:00 AM | BioXcel Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/14/2023 10:30 AM | Balasubramanian Suganthi (Reporting) BioXcel Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:52 PM | Agarwal Rashmi (Reporting) BioXcel Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:51 PM | Agarwal Anesha (Reporting) BioXcel Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 5:55 PM | Agarwal Akrati (Reporting) BioXcel Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 5:57 PM | Agarwal Vipin (Reporting) BioXcel Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:01 PM | BioXcel Therapeutics (Issuer) Gibson Marshal D. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:03 PM | BioXcel Therapeutics (Issuer) Gupta Indu R. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:05 PM | BioXcel Therapeutics (Issuer) Gupta Tarun K. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:08 PM | BioXcel Therapeutics (Issuer) Jain Anita (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:10 PM | BioXcel Therapeutics (Issuer) Jain Diwakar (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:12 PM | BioXcel Therapeutics (Issuer) Patel Bina Jatin (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:14 PM | BioXcel Therapeutics (Issuer) Patel Jatin Markand (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:16 PM | BioXcel Therapeutics (Issuer) Patel Krunal Dilip (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:21 PM | BioXcel Therapeutics (Issuer) Sood Alka (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/13/2023 6:24 PM | BioXcel Therapeutics (Issuer) Sood Pardeep Kumar (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/10/2023 5:20 PM | BioXcel Therapeutics (Issuer) Nandabalan Krishnan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/04/2023 5:00 AM | BioXcel Holdings, Inc. (Filed by) BioXcel Therapeutics (Subject)
| Form SC 13G/A | |